Finding a way through a tight deal space
Leaders of WilmerHale’s life sciences practice share trends they see regarding acquisitions and initial public offerings.
presented by
presented by
Navigating the Life Science M&A Savannah
Still recovering from a market correction two years ago, and with a scarcity of attractive targets and ongoing macroeconomic uncertainty, the life sciences dealmaking space is in a state of flux.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
presented by
Collaboration at Fenwick & West Steers Firm through complex deals
After a relatively slow 2016 for life sciences deals...
presented by
Newly united Arnold & Porter Kaye Scholer surveys changed life sciences deal environment
Last year proved a slow one for dealmaking in the life sciences space. But that didn’t stop two of the major legal players in it from consummating one themselves: In November, Arnold & Porter and Kaye Scholer agreed to merge, bringing together two formidable healthcare practices.